跳至主要内容
临床试验/JPRN-UMIN000005131
JPRN-UMIN000005131已完成未知

Prospective study for correlation between disease progression and detection of T790M in plasma DNA using MBP-QP method in non-small cell lung cancer patients treated with EGFR tyrosine kinase inhibitors - Prospective study for correlation between disease progression and T790M detection in plasma DNA in non-small cell lung cancer (HASAT study)

Foundation for Biomedical Research and Innovation0 个研究点目标入组 80 人开始时间: 2011年3月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.Non-small cell lung cancer patients with EGFR mutations which is related with acquired resistance such as T790M. 2.Non-small cell lung cancer patients who is not appropriated for the study determined by physician in charge.

研究者

相似试验